Go to the list of all blogs
Abhoy Sarkar's Avatar
published in Blogs
Feb 13, 2026
CINF vs ALL Stock Comparison: Earnings Preview Ahead of Q4 Results

CINF vs ALL Stock Comparison: Earnings Preview Ahead of Q4 Results

Key Takeaways

  • Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion.

  • CINF has beaten EPS estimates in the last four quarters, including a $0.84 upside in Q3 2025.

  • Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.

  • ALL also announced a $4 billion share buyback and an 8% dividend increase, signaling confidence.

  • CINF trades at a higher P/E (12.85) with lower volatility (beta 0.65), while ALL offers an attractive 5.45 P/E and beta 0.23.

  • Both insurers benefit from premium growth, though 2026 softening market pricing may pressure margins.

Why This Comparison Matters

CINF’s upcoming Q4 report provides insight into regional property-casualty underwriting discipline amid rising premiums and catastrophe exposure. The company’s independent agent model and equity-heavy investment portfolio have historically supported consistent EPS beats.

ALL, a larger national insurer, demonstrates scale advantages across auto, home, and specialty lines. Its recent blockbuster results highlight pricing power and operational efficiency. Comparing the two helps investors assess trade-offs between stability and growth in the P&C sector, particularly as market pricing softens. Metrics such as combined ratio, investment income, and guidance will be critical in differentiating the two approaches.

CINF Earnings Preview

CINF will report Q4 and full-year 2025 results after market close on February 9, 2026, with a conference call on February 10 at 11 a.m. ET. Analysts expect EPS of $2.86–$2.89, down about 8% YoY, with revenue around $2.91 billion (up ~10%).

Key metrics include:

  • Property-casualty earned premiums and underwriting results

  • Combined ratio, with targets below 100%

  • Net investment income from its equity-heavy portfolio

CINF’s track record of four consecutive EPS beats (e.g., Q3 2025 EPS $2.85 vs. $2.01 expected) underlines resilience, though catastrophe exposure can drive volatility in quarterly performance.

ALL Context and Recent Results

Allstate reported strong Q4 2025 earnings on February 4, 2026:

  • EPS: $14.31 vs. $8.72 consensus (+64%)

  • Revenue: $17.3 billion, slightly below expectations

  • Full-year net income: $10.2 billion, doubling from 2024

ALL also declared a $4 billion share repurchase and an 8% dividend increase ($1.08 quarterly). Its combined ratio improved to 72.9%, reflecting effective pricing and operational efficiency. The next earnings report is expected in late April, keeping momentum high.

  • Scale & Strategy: CINF focuses on specialty commercial P&C via independent agents, leveraging equity portfolios for investment income. ALL leverages national auto and direct channels for higher ROE and EPS growth.

  • Valuation & Volatility: ALL’s lower P/E and strong balance sheet make it attractive for growth, while CINF offers stability and dividend reliability.

  • Growth Drivers: Both benefit from premium hikes, though softening pricing in 2026 may cap margin expansion.

Tickeron AI Take

Tickeron’s AI models currently favor ALL due to earnings momentum, buyback support, and attractive valuation, positioning it strongly in the competitive P&C landscape. CINF remains appealing for conservative investors seeking consistent dividends and historical beats, but near-term pricing pressures may limit upside. Overall, ALL shows a higher probability of outperformance in the coming quarter, barring surprises from CINF’s Q4 report.

Tickeron AI trading bot

Disclaimers and Limitations

Related Ticker: CINF, ALL

CINF in -0.80% downward trend, sliding for three consecutive days on August 12, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CINF declined for three days, in of 269 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CINF as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CINF moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CINF crossed bearishly below the 50-day moving average on August 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CINF advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 257 cases where CINF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.594) is normal, around the industry mean (2.141). P/E Ratio (8.177) is within average values for comparable stocks, (15.691). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.096). Dividend Yield (0.021) settles around the average of (0.023) among similar stocks. P/S Ratio (1.948) is also within normal values, averaging (1.597).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CINF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.

Market Cap

The average market capitalization across the Property/Casualty Insurance Industry is 13.85B. The market cap for tickers in the group ranges from 93.9K to 132.58B. CB holds the highest valuation in this group at 132.58B. The lowest valued company is UNAM at 93.9K.

High and low price notable news

The average weekly price growth across all stocks in the Property/Casualty Insurance Industry was 1%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 17%. PRHI experienced the highest price growth at 44%, while SKWD experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Property/Casualty Insurance Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -39% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 65
Price Growth Rating: 48
SMR Rating: 60
Profit Risk Rating: 52
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
CINF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of property casualty insurance services

Industry PropertyCasualtyInsurance

Profile
Details
Industry
Property Or Casualty Insurance
Address
6200 S. Gilmore Road
Phone
+1 513 870-2000
Employees
5705
Web
https://www.cinfin.com
Interact to see
Advertisement
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Coca-Cola (KO) reports Q4 2025 earnings on February 10, 2026, with consensus EPS of $0.56 and revenue of $12.05 billion. PepsiCo (PEP) beat Q4 2025 estimates on February 3, reporting adjusted EPS of $2.26 (vs. $2.24 expected) and revenue of $29.34 billion.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.